BioNTech (BNTX-Q)
NASDAQ:BNTX
98.68
0.39
(0.39%) 1d
Financials
Technical Analysis
Buy, Sell or Hold?
Related posts
Nervous markets await Nvidia
This summary was created by AI, based on 1 opinions in the last 12 months.
BioNTech (BNTX-Q) has recently received positive feedback from stock analysts, highlighting its strong performance in the market. The stock has been designated as a 'Top Pick' as of December 21, 2023, with a notable increase of 9.3%. Analysts, including Michael O'Reilly from Stockchase Research, emphasize the importance of risk management in investment strategies, suggesting that investors adjust their stop-loss order from $78 to $95 to secure profits while allowing for potential further gains. Overall, the sentiment around BioNTech appears optimistic, reflecting the company's ongoing successes and growth potential in the biopharmaceutical sector. As always, investors should keep abreast of market trends and company developments to make informed decisions.
This $24 billion German based pharma company has received approvals to continue advancement into a new uterine cancer treatment. It trades at 8x trailing earnings, 1.1x book and supports a 23% ROE. Cash reserves are growing, while stock is bought back. We recommend placing a stop-loss at $78, looking to achieve $137 -- upside potential of 31%. Yield 0%
(Analysts’ price target is $137.07)The $28 billion biotech just received FDA approval of their updated COVID vaccine. It trades at 6x earnings, 1.3x book and supports a 23% ROE. We like that cash reserves are growing, while shares are bought back and debt is retired. We recommend placing a stop-loss at $100, looking to achieve $161 -- upside potential of 40%. Yield 0%
(Analysts’ price target is $161.34)Provides the key insight into mRNA that underlies the Covid vaccine. The mRNA technology can be developed into therapies that are targeted and safe. They are working on a flu vaccine as well as a cancer vaccine. Their pipeline is vast and the coronavirus vaccine is giving a huge cash hoard to pay for R&D. (Analysts’ price target is $185.00)
- «
- ‹
- 1
- ›
- »
BioNTech(BNTX-Q) Rating
Ranking : 4 out of 5
Bullish - Buy Signals / Votes : 2
Neutral - Hold Signals / Votes : 0
Bearish - Sell Signals / Votes : 0
Total Signals / Votes : 2
BioNTech(BNTX-Q) Frequently Asked Questions
What is BioNTech stock symbol?
BioNTech is a American stock, trading under the symbol BNTX-Q on the NASDAQ (BNTX). It is usually referred to as NASDAQ:BNTX or BNTX-Q
Is BioNTech a buy or a sell?
In the last year, 2 stock analysts published opinions about BNTX-Q. 2 analysts recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for BioNTech.
Is BioNTech a good investment or a top pick?
BioNTech was recommended as a Top Pick by on . Read the latest stock experts ratings for BioNTech.
Why is BioNTech stock dropping?
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
Is BioNTech worth watching?
2 stock analysts on Stockchase covered BioNTech In the last year. It is a trending stock that is worth watching.
What is BioNTech stock price?
On 2025-05-23, BioNTech (BNTX-Q) stock closed at a price of $98.68.
Our PAST TOP PICK with BNTX has triggered its stop at $95. To remain disciplined, we recommend covering the position at this time.